LEDERMAN SETH (Chief Executive Officer) reported 3 transactions at TONIX PHARMACEUTICALS HOLDING CORP.
Review the transaction codes below to understand the nature of each event.
Common Stock, $0.001 par value
Shares
−5.18
Price / share
$3.38
Trade value
$17.51
% of position
Common Stock, $0.001 par value
Shares
−0.22
Price / share
$3.30
Trade value
$0.73
% of position
Common Stock, $0.001 par value
Shares
−1.00
Price / share
$0.15
Trade value
$0.15
% of position
Net shares
−6.40
Net value
-$18.38
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value Direct | 2/5/2025 | J · J | −5.18 | $3.38 | $17.51 | 50.9% | 10.18 | 5.00 |
| Common Stock, $0.001 par value Indirect | 2/5/2025 | J · J | −0.22 | $3.30 | $0.73 | 18.0% | 1.22 | 1.00 |
| Common Stock, $0.001 par value Indirect | 2/5/2025 | J · J | −1.00 | $0.15 | $0.15 | New position | 1.00 | 0.00 |
| Total | −6.40 | -$18.38 | ||||||
Stock Option
Common Stock
123.96K shares
Shares
+123.96K
Strike price
8.05
Held after
123.96K
Exercisable
—
Stock Option
Common Stock
123.96K shares
Shares
+123.96K
Strike price
10.0625
Held after
123.96K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Direct | Common Stock123.96K shares | 2/25/2025 | A · Award | +123.96K | 8.05 | — | 123.96K |
| Stock Option Direct | Common Stock123.96K shares | 2/25/2025 | A · Award | +123.96K | 10.0625 | — | 123.96K |
Common Stock, $0.001 par value
DirectCommon Stock, $0.001 par value
IndirectCommon Stock, $0.001 par value
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, $0.001 par value | 5.00 | Direct |
| Common Stock, $0.001 par value | 1.00 | Indirect |
| Common Stock, $0.001 par value | 1.00 | Indirect |
| Total | 7.00 | 5.00 direct·2.00 indirect |